Home OTC Market Litigation Blog Press Subscribe Racing Contact
   Consultants to public companies, brokers, attorneys, regulators and OTC Markets Group, Inc.

Service to Public Companies

“I don’t know of anybody who has a better grasp of the OTC markets than George Sharp”
    - Louis Sapi, Managing Partner, HS & Partners LLP | Chartered Professional Accountants and Business Advisors

Years of investigation and forensic research on companies that trade on the OTC Markets platform have afforded George and his associates the credibility that legitimate public issuers seek.  Many reverse takeovers of public shells result in the devastation of the acquiring company's business, the CEO/President's reputation, and retail investor accounts, only because the acquirer didn't investigate the history of any shell offered for sale. George and his team are available to provide a complete analysis of any shell and provide a forward look as to any pitfalls the potential acquirer may encounter, or make recommendation as to a course of action to avoid those pitfalls.

Mutually beneficial relationships with OTC Markets Group, Inc., the United States Securities and Exchange Commission (SEC), the Financial Industry Regulatory Association (FINRA), the Alberta Securities Commission (ASC), various American and Canadian authorities, and a score of SEC attorneys, enable George to help his clients stay on side of rules and regulations. Whether he is the public face of a company or an advisor in its boardroom, an association with George provides a measure of security to investors seeking to avoid the common OTC fly-by-night share selling scheme.

“George’s expertise in tracking small and microcap market activity makes him a valuable asset as we improve market transparency.” - Matthew Fuchs, Executive Vice President of Market Data and Strategy, OTC Markets Group, Inc.

George and his team are offering services to broker-dealers, securities depositories, market makers, investors, attorneys, and a select few publicly traded companies, including:
  • Due Diligence
    (Individuals and Corporate)
  • Fraud Mitigation
  • Forensic Analysis
  • Investor Outreach
  • Public Relations
  • Asset Sale/Acqusition
  • Angel/Equity Financing
  • Advisory Board Participation
  • Business Consulting